McDonald’s India Launches Multi-Millet Burger Bun with CFTRI and CSIR to Boost Indigenous Nutrition and Support Millet Movement – Firstpost

Sitharaman proposes 5 medical tourism hubs, Biopharma mission at Rs 10,000 crore – Firstpost

  • Post category:Latest News
Share this Post


In the Budget 2026-27, Finance Minister Nirmala Sitharaman has proposed setting up five medical tourism hubs and launching a ‘Biopharma Shakti programme’ with an outlay of Rs 10,000 crore.

In the Budget 2026-27, Finance Minister Nirmala Sitharaman on Sunday proposed to set up five medical tourism hubs and launch a ‘Biopharma Shakti programme’ with an outlay of Rs 10,000 crore over the next five years.

Sitharaman said, “To promote India as a hub for medical tourism services, I propose to launch a scheme to support states in establishing five regional medical hubs in partnership with the private sector.”

Sitharaman said that these hubs will serve as integrated healthcare complexes that combine medical, educational, and research facilities.

STORY CONTINUES BELOW THIS AD

These medical tourism hubs will have AYUSH centres, medical value tourism facilitation centres, and infrastructure for diagnostics, post-care, and rehabilitation. She added that these hubs will provide diverse job opportunities for health professionals, including doctors and allied health professionals (ALPs).

Follow our live Budget 2026-27 coverage
here

Sitharaman also proposed to set up three new All India Institute of Ayurveda.

Sitharaman further proposed the Biopharma Shakti with an outlay of Rs 10,000 crore over the next five years to build the ecosystem for domestic production of biologics and biosimilars.

The strategy will include a biopharma-focused network with three new National Institutes of Pharmaceutical Education and Research, popularly known as NIPERS, and upgrading seven existing ones, Sitharaman said.

“It will also create a network of 1,000 accredited India clinical trials sites. We propose to strengthen the central drug standard control organisation to meet global standards and approve timeframes, through an approval time frames through a dedicated scientific review cadre, and specialists,” Sitharaman further said.

This is a developing story.

End of Article



Source link

Share this Post

Leave a Reply